Anti-TNF Agents Linked to Increased Risk for IBD Anti-TNF Agents Linked to Increased Risk for IBD
A new study finds that patients with autoimmune disease treated with anti- tumor necrosis factor alpha have an increased risk of developing inflammatory bowel disease.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Rheumatology News Source Type: news
More News: Allergy | Allergy & Immunology | Autoimmune Disease | Inflammatory Bowel Disease | Rheumatology | Study